Shares of Ocular Therapeutix were up 17.43% to $7.41 on heavy trading volume early-afternoon Thursday as the Bedford, MA-based company is partnering with the Tarrytown, NY-based biotechnology company Regeneron Pharmaceuticals . Under the agreement, the companies will collaborate on the development of a sustained release formulation of aflibercept, Regeneron's retinal disease treatment.
http://ift.tt/2dMGNQS
No comments:
Post a Comment